NEW YORK and LONDON, June 15, 2016
Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, today announced that Dr. Gur Roshwalb, Chief Executive Officer, will participate in a fireside chat and provide an overview of the company at the 2016 JMP Life Sciences Conference on Tuesday, June 21, 2016 in New York. The company is scheduled to present at 4:00 p.m. EDT.
